3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia
8
Leukemia, Myeloid, Chronic-Phase
7
Burkitt Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Philadelphia Chromosome
2
Pancreatic Neoplasms
2
Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Glioma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Interventions
pembrolizumab
3
Nivolumab
3
Ifosfamide
3
Doxorubicin
3
AZD 6244
3
selinexor
2
pazopanib
2
fludarabine phosphate
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
thymoglobulin
1
tazemetostat
1
metarrestin
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Thiotepa
1
Tacrolimus
1
Stem Cell Transplantation
1
Specimen Handling
1
Sirolimus
1
Proton Therapy
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Liquid Biopsy
1
Ipilimumab
1
Injections
1
Etoposide
1
Cyclosporins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
Dasatinib
×
1 year
×
Clear all
No trials found.